糖尿病与代谢杂志

体积 3, 问题 9 (2012)

研究文章

Orally-Administered Chemokine Receptor CCR2 Antagonist CCX140-B in Type 2 Diabetes: A Pilot Double-Blind, Randomized Clinical Trial

Markolf Hanefeld, Ernest Schell, Ioanna Gouni-Berthold, Martin Melichar, Ivana Vesela, Dan Johnson, Shichang Miao, Tim J Sullivan, Juan C Jaen, Thomas J Schall, Pirow Bekker and The CCX140-B Diabetes Study Group

研究文章

Impact of Iron Indices, Mitochondrial Oxidative Capacity, Oxidative Stress and Inflammatory Markers on Insulin Resistance and Secretion: A Pathophysiologic Perspective

Jayanthy Ramesh, Mohammad Ibrahim Shaik and Jayanthy Srivalli

评论文章

Innovative Treatments in Diabetes Type 1

Bernadette Barbara Lenartowicz and Emilian Snarski

研究文章

The Effect on Quality of Life and Psychiatric Symptoms of Other Comorbid Chronic Diseases on Patients with Type 2 Diabetes Mellitus

Ilkay Ozdemir, Cicek Hocaoglu, Mustafa Kocak and Onder H Ersoz

研究文章

Association of Alpha-2 Beta-1 Integrin Polymorphism with Retinopathy in Diabetic Patients

Nadeem Afzal, Nagi AH, Muhammad Imran, Abu Zafar, Amtul Musawar, Romeeza Tahir, Sarwar Abbas, Afia Abbas, Shakeela Zaman and Shah Jahan

体积 3, 问题 9 (2012)

Orally-Administered Chemokine Receptor CCR2 Antagonist CCX140-B in Type 2 Diabetes: A Pilot Double-Blind, Randomized Clinical Trial

Impact of Iron Indices, Mitochondrial Oxidative Capacity, Oxidative Stress and Inflammatory Markers on Insulin Resistance and Secretion: A Pathophysiologic Perspective

Innovative Treatments in Diabetes Type 1

The Effect on Quality of Life and Psychiatric Symptoms of Other Comorbid Chronic Diseases on Patients with Type 2 Diabetes Mellitus

Association of Alpha-2 Beta-1 Integrin Polymorphism with Retinopathy in Diabetic Patients

期刊亮点

期刊索引于